EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)

糖尿病流行病学干预和并发症试验 (EDIC)

• 批准号: 7375851
• 负责人: JOHN P BANTLE
• 金额: $ 2.58万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375851
• 关键词: EPIDEMIOLOGY; DIABETES; INTERVENTIONS; COMPLICATIONS; TRIAL

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Diabetes Control and Complications Trial (DCCT) study results were announced in June, 1993 and demonstrated that intensive treatment of type I diabetes with maintenance of good control of glycemia retarded retinopathy, nephropathy, and neuropathy. DCCT subjects continue to be followed as participants in the Epidemiology of Diabetes Intervention and Complications (EDIC).

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。糖尿病控制和并发症试验（DCCT）研究结果于1993年6月公布，表明I型糖尿病的强化治疗与维持良好的糖尿病控制延缓视网膜病变、肾病和神经病变。DCCT受试者继续作为糖尿病干预和并发症流行病学（EDIC）的参与者接受随访。